Results 11 to 20 of about 37,585 (155)

Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood [PDF]

Haematologica, 2014
Refractory cytopenia of childhood is the most common subtype of myelodysplastic syndrome in children. In this study, we compared the outcome of immunosuppressive therapy using horse antithymocyte globulin (n=46) with that using rabbit antithymocyte ...
Ayami Yoshimi, Marry M. van den Heuvel-Eibrink, Irith Baumann, Stephan Schwarz, Ingrid Simonitsch-Klupp, Pascale de Paepe, Vit Campr, Gitte Birk Kerndrup, Maureen O’Sullivan, Rita Devito, Roos Leguit, Miguel Hernandez, Michael Dworzak, Barbara de Moerloose, Jan Starý, Henrik Hasle, Owen P. Smith, Marco Zecca, Albert Catala, Markus Schmugge, Franco Locatelli, Monika Führer, Alexandra Fischer, Anne Guderle, Peter Nöllke, Brigitte Strahm, Charlotte M. Niemeyer   +26 more
doaj   +7 more sources

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia [PDF]

Haematologica, 2017
For treatment of severe aplastic anemia, immunosuppressive therapy with horse antithymocyte globulin results in superior response and survival compared with rabbit antithymocyte globulin.
Natasha Kekre, Ying Zhang, Mei-Jie Zhang, Jeanette Carreras, Parvez Ahmed, Paolo Anderlini, Elias Hallack Atta, Mouhab Ayas, Jaap Jan Boelens, Carmem Bonfim, H. Joachim Deeg, Neena Kapoor, Jong-Wook Lee, Ryotaro Nakamura, Michael A. Pulsipher, Mary Eapen, Joseph H. Antin   +16 more
doaj   +3 more sources

Rabbit antithymocyte globulin (Thymoglobulin®) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients [PDF]

Haematologica, 2013
Rabbit antithymocyte globulin-Genzyme™ is used to prevent graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Common disadvantages of treatment are infectious complications.
Il-Kang Na, Friedrich Wittenbecher, Mikalai Dziubianau, Anne Herholz, Angela Mensen, Désirée Kunkel, Olga Blau, Igor Blau, Eckhard Thiel, Lutz Uharek, Carmen Scheibenbogen, Kathrin Rieger, Andreas Thiel   +12 more
doaj   +2 more sources

APPLICATION OF ANTITHYMOCYTE GLOBULIN IN CHILDREN AFTER CADAVER KIDNEY TRANSPLANTATION. RETROSPECTIVE ANALYSIS

Педиатрическая фармакология, 2011
The article provides results of in-house research to assess the impact of induction immunosuppression using antithymocyte globulin (ATG) on the clinical course of post-transplantation period after kidney transplantation.
V.A. Goryainov, M.M. Kaabak, N.N. Babenko, A.K. Zokoev, E.A. Molchanova, L.A. Shishlo, M.M. Morozova   +6 more
doaj   +3 more sources

Acute Lung Injury during Antithymocyte Globulin Therapy for Aplastic Anemia [PDF]

Canadian Respiratory Journal, 2009
The case of a 33-year-old man with aplastic anemia who experienced recurrent episodes of hypoxemia and pulmonary infiltrates during infusions of antithymocyte globulin (ATG) is described.
Ewan Christopher Goligher, Christine Cserti-Gazdewich, Meyer Balter, Vikas Gupta, Joseph E Brandwein   +4 more
doaj   +4 more sources

Antithymocyte globulin preparations after heart transplantation: Cytokine responses in vivo and in vitro

, 1995
It is accepted that antithymocyte globulin (ATG) preparations vary in their bioactivity and side effects. However, this is poorly documented in the literature.
Grant, S. C D, Brenchley, P. E C, Yonan, N., Lamb, W. R., Hutchinson, I. V.   +4 more
core   +10 more sources

Baseline characteristics according to the dosage of antithymocyte globulin.

, 2023
Baseline characteristics according to the dosage of antithymocyte globulin.
Dong Hyun Kim (184121), Young Hoon Kim (554681), Joo Hee Jung (4567987), Yu-Mee Wee (14701181), Mi Joung Kim (14701184), Hyunwook Kwon (4091746), Seong Jun Lim (11383763), Duck Jong Han (3998090), Monica Young Choi (14701187), Sung Shin (3401819), Youngmin Ko (3333819)   +10 more
core   +1 more source

Changes in Sepsis Biomarkers after Immunosuppressant Administration in Transplant Patients

Mediators of Inflammation, 2021
Sepsis biomarkers change continuously during the postoperative period. We aimed to demonstrate the influence of immunosuppressants after transplantation (Tx) on presepsin, procalcitonin, CRP, white blood cells, and IL-6.
Janka Franeková, Marek Protuš, Eva Kieslichová, Aleš Březina, Jitka Komrsková, Jiří Vymětalík, Antonín Jabor   +6 more
doaj   +1 more source

Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children

Haematologica, 2014
Some prospective studies showed that rabbit antithymocyte globulin was inferior to horse antithymocyte globulin as first-line therapy for patients with severe aplastic anemia.
Dae Chul Jeong, Nack Gyun Chung, Bin Cho, Yao Zou, Min Ruan, Yoshiyuki Takahashi, Hideki Muramatsu, Akira Ohara, Yoshiyuki Kosaka, Wenyu Yang, Hack Ki Kim, Xiaofan Zhu, Seiji Kojima   +12 more
doaj   +1 more source

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report

BMC Nephrology, 2020
Background The occurrences of hyperuricemia and acute kidney injury after antithymocyte globulin treatment are unusual in kidney transplant recipients.
Yohan Park, Byung Ha Chung, Cheol Whee Park, Yong-Soo Kim, Chul Woo Yang   +4 more
doaj   +1 more source